Abstracts of the short communications
Victoria Losinski, Christina Cipolle, University of Minnesota, St Paul, USA
Realizing the transformation of a profession: the case study of the State of Minnesota
Susanne Kaae, Janine Morgall Traulsen, Birthe Søndergaard, Lotte Stig Haugbølle The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark
The first Danish publicly reimbursed cognitive service in community pharmacies on a national scale—why and how did it become reality?
I. Krass1, C. Delaney2, S. Glaubitz3, T. Kanjanarach1. (1) Faculty of Pharmacy, Sydney, Australia. (2) St Vincent’s Hospital Sydney, Australia. (3) University of Utrecht, the Netherlands
Patient satisfaction with Pharmacy Diabetes Disease State Management (DSM) Services: validation of an instrument
Mrs. Mirjam E.A.P. Kokenberg, Quality Institute for Pharmaceutical Care, Kampen, The Netherlands
Best practice polypharmacy: the road from a single project to a nationwide best practice
-
In 1999, 2000 and 2001 QIPC studied the organization, feasibility the medication changes and the financial outcomes of polypharmacy intervention in three pharmacies.
-
In 2004 a major healthcare insurance company showed interest in the polypharmacy intervention and financed an implementation study in 14 pharmacies and 31 physicians, performed by QIPC.
-
In 2005 the Dutch Ministry of Health nominated the QIPC polypharmacy intervention (together with the DGV* polypharmacy intervention) as ‘Best Practice’. QIPC and DGV developed a joint Best Practice Polypharmacy structure. A nationwide web based data system was developed for registration of the interventions on patient level.
-
In 2006 the Dutch Ministry of Health partially subsidized the nationwide implementation of this joint Best Practice Polypharmacy project by QIPC and DGV. This Best Practice consists of:
-
Selection of patients
-
Medication review by pharmacist and physician separately
-
Joint consultations between pharmacist and physician
-
Evaluation on patient level
-
Monitoring and evaluation of the interventions
-
Continuity of the interventions
-
The pharmacists and physicians are coached by DGV and QIPC for 9 months.
-
-
In 2007 the implementation will continue.
-
The published studies in 1999, 2000 and 2001 showed that the polypharmacy interventions are feasible and worthwhile. DRP’s were found and solved, the costs of medication decreased.
-
The study of 2004 (839 patients) shows that in 36% of the reviewed patients a medication change is necessary; stopping medication happens most often (44%), followed by change in doses (23%), change of medication (20%) and starting new medication (13%). 35% of the patients says to feel better after the intervention, 97% of the patients thinks a periodically performed medication review very important, 36% of the pharmacists and physicians thinks their professional working relation improved.
-
In 2006 43 groups of pharmacists and physicians are now implementing the ‘Best Practice Polypharmacy’, and preliminary data (315 patients) show that in about 50% of the patients a medication change is necessary.
-
In 2007 QIPC and DGV aim at coaching 30 groups intensively and 200 groups less intensively.
Veerle Foulon1, S. Sirmoens1, G. Laekeman1 and P. de Witte2. (1) Research Centre for Pharmaceutical Care and Pharmaco-economics, K.U.Leuven, Belgium. (2) Programme Director, Faculty of Pharmaceutical Sciences, K.U.Leuven, Belgium
A conceptual framework for the implementation of pharmacy practice research in the education of students at the K.U.Leuven, Belgium
Divaldo Pereira de Lyra Jr., Fabiola Sulpino Vieira, Manoel Roberto da Cuz Santos, Federal University of Sergipe, Aracuja, Brazil
Introducing actions to implement Pharmaceutical Care research in Brazil
Abstracts of the posters
H. Oller Dolcet, S.I. Benrimoj, F. Fernandez-Llimo. Faculty of pharmacy, Sydney, Australia
A theoretical framework for the implementation of patient-oriented pharmacy services using a quality management system
Costa F.A.1, Guerreiro M.P., Hughes C., McElnay J.C. (1) Institute of Health Sciences Egas Moniz, Portugal
Applying the Behavioural Pharmaceutical Care Scale (BPCS) in Portugal
C. Rossing (crapharmakon.dk), H. Herborg, L. Sorensen, Pharmakon, Hillerød, Denmark
Adherence problems among type 2-diabetics
Marleen Haems, Kava, Antwerp, Belgium
KAVA-Foldermanagement: a contribution for written patient information of good quality
Lastra CF, Modamio P, Sebarroja L, Casasin T, Marifio EL. Clinical Pharmacy and Pharmacotherapy Unit. Faculty of Pharmacy. University of Barcelona. Avda. Joan XXlll sin. Barcelona (Spain)
EDEMED: a computer tool about Medication Errors and drug safety for implementation of pharmaceutical care
Feletto E, Oller Dolcet H, Femandez-Llirnos F, Roberts A, Benrimoj SI, Faculty of Pharmacy, Sydney, Australia
An international approach to linking quality systems and business capabilities to enhance viability and the implementation of patient orientated services in community pharmacy
Feletto E, Dunphy D, Palmer I, Benrimoj SI, Roberts A. Faculty of Pharmacy, Sydney, Australia
An industry approach to practice change in community pharmacy
Feletto E, Dunphy D, Palmer I, Benrimoj SI, Roberts A, Faculty of Pharmacy, Sydney, Australia
Practice change in community pharmacy—tools for service lmplementation
-
10 focus groups (n = 102)
-
24 case studies of community pharmacies
-
a quantitative mail survey with 2,022 community pharmacy owners, response rate of 28.5% (n = 575)
Feletto. E, Roberts, A & Benrimoj SI. Faculty of Pharmacy, Sydney. Australia
Optimising business viability in Australian community pharmacies by integrating cognitive pharmacy services
Catriona Bradley1,2, Martin Hemman1. (1) School of pharmacy, Trinity College Dublin, Ireland. (2) Boots the Chemist, Ireland
Studies of health promotion and weight control in Community Pharmacy in the Republic of Ireland
Patrick Eichenberger1, Marion Schaefer2, Kurt E. Hersberger1. (1) Institute of Clinical Pharmacy. University of Basel, Switzerland; (2) lnstitute of Clinical Pharmacology, Charité, Berlln, Germany
Provision of pharmaceutical care by Swiss and German community pharmacists
When delivering a new prescription for chronic conditions pharmacist reported (freq. Of activity in %) | Mean scores ± SD and reliability estimates (Cronbach’s α) range 1–5 (1 = never 5 = always) | ||||||
---|---|---|---|---|---|---|---|
to document therapeutic objectives | to question what patients hope to achieve from drug therapy | to document the patient’s medical condition | to check for drug-related problems | Direct patient care activities | Referral and consultation activities | Instrumental activities | |
CH | 4.7% | 15.8% | 20.8% | 85.2% | 2.2 ± 0.7 0.797 | 2.2 ± 0.6 0.740 | 2.9 ± 0.8 0.673 |
BW | 6.6% | 25.9% | 16.2% | 83.0% | 1.9 ± 0.9 0.884 | 2.5 ± 0.7 0.755 | 2.7 ± 0.8 0.706 |
SA | 7.7% | 23.1% | 16.3% | 95.5% | 2.1 ± 0.9 0.854 | 2.6 ± 0.7 0.770 | 2.7 ± 0.8 0.684 |